In 2002, Mr. Shuster founded Shuster Capital, a strategic and operating advisor to and angel investor in life science companies, and has served as its CEO since that time. From June 2003 to November 2007, Mr. Shuster served as CEO of Kemia, Inc., a drug discovery and development company. From February 2000 to December 2001, Mr. Shuster held various operating executive positions at Invitrogen Corporation. Between 1994 and 1999, Mr. Shuster served as CFO and other executive positions at Pharmacopeia, Inc. Mr. Shuster joined Human Genome Sciences, Inc. as its first employee in September 1992 and served as its EVP, operations and finance until 1994. Since May 2014 Mr. Shuster has served as Board Audit Committee Chairman for HTG Molecular Diagnostics (NASDAQ: HTGM). Mr. Shuster served as a member of the board of directors for Response Biomedical Corporation, Complete Genomics, Mast Therapeutics, Inc. Mr. Shuster received a B.A. in Economics from Swarthmore College and an M.B.A. from Stanford University.